Invivyd (IVVD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IVVD Invivyd

Watchlist

1.015
-0.025-2.40%

Trading Nov 7 13:41 ET

121.23MMarket Cap-563P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference
GlobeNewswireNov 6 08:01 ET
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
GlobeNewswireNov 6 07:01 ET
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
BenzingaOct 30 12:05 ET
Invivyd Initiated at Buy by EF Hutton
Dow JonesOct 30 09:14 ET · Ratings
EF Hutton Initiates Coverage On Invivyd With Buy Rating, Announces Price Target of $9
BenzingaOct 30 09:03 ET · Ratings
Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5
Moomoo NewsOct 29 18:31 ET · Ratings

Comments

Trytosaveabit

Oct 29 06:14

Update

$Invivyd (IVVD.US)$ Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA (Pemivibart) Provided Substantial Protection From Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With No Additional Doses, In Immunocompetent Participants
GlobeNewswire· 12 mins ago
Following strong protection (84% relative risk reduction versus placebo) demonstrated through month 6 with pemivibart, CANOPY clinical trial participants were followed for an additional six-month pe...

Jaguar8

Oct 16 06:41

NEWS

$Invivyd (IVVD.US)$
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024
Invivyd (Nasdaq: IVVD) announced upcoming presentations of pemivibart data from its Phase 1 and Phase 3 clinical trials at IDWeek 2024 in Los Angeles, October 16-19, 2024. The presentations include:
An oral presentation on clinical efficacy endpoints from the Phase 3 CANOPY Study
A poster on results from a Phase 1 first-in-human study
A poster on pharmacokinetics and serum virus neutral...

Kevin Lehmann

Oct 15 21:23

$Invivyd (IVVD.US)$ i support this stock

MARKET-TEST-DUMMY

Oct 13 13:57

Will it be

$Invivyd (IVVD.US)$ 1.15 tomorrow?

Tonyco

Oct 12 10:11

The Hunt

New targets for next week:
$Invivyd (IVVD.US)$ - makes COVID antibodies, w/ a phase 3 trial completing soon.
$ReNew Energy Global (RNW.US)$ - unconventional and renewable energy company in India.
$Vivid Seats (SEAT.US)$ - Online marketplace for event tickets. Good competition vs. $Live Nation Entertainment (LYV.US)$
$Array Technologies (ARRY.US)$ Tracking equipment and software for solar panels, allowing them to increase efficiency following the sun through the day.

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Top Gainers Yesterday

Intraday-0.34%

IVVD Invivyd

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target